CIK 0001672619 · Non-accelerated filer
Enliven Therapeutics, Inc.
Sign in to watch- Ticker
- ELVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811523849
- Phone
- 650-547-5814
- Business address
- 205 PARK ROAD, BURLINGAME, CA, 94010
- Former names
- IMARA Inc.
- 8-K Event Material agreement · Other events
- DEFM14A Deal DEFM14A
- PREM14A Deal PREM14A
- DEFA14A Proxy Proxy Materials
- 8-K Event Material agreement · Executive or director change · Other events
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Agreement ended
- 4 Open-market buy 10% owner bought 83,199 shares at $1.11 ($92,243)
- 4 Open-market buy 10% owner bought 33,430 shares at an average $1.14 ($38,027)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy 10% owner bought 41,145 shares at an average $1.23 ($50,413)
- 10-Q Report Quarterly Report
Page 32 of 40 · 798 filings